Prevention of crescentic glomerulonephritis by immunoneutralization of the fractalkine receptor CX3CR1: Rapid Communication

Abstract
No abstract available
Funding Information
  • National Institutes of Health (R29 DK-49832, AR-40770, DK20043, 5T32AI07233)
  • Novartis
  • National Kidney Foundation